688131 皓元醫藥
按盤價 
72.560 -2.000 (-2.682%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.138 | 7.975 | 7.484 | 5.278 | 9.350 |
| 總資產報酬率 ROA (%) | 1.061 | 4.065 | 4.158 | 3.272 | 6.474 |
| 投入資產回報率 ROIC (%) | 1.203 | 4.607 | 4.708 | 3.785 | 7.555 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.425 | 47.104 | 47.965 | 45.168 | 51.444 |
| 營業利潤率 (%) | 10.182 | 10.315 | 10.432 | 6.826 | 14.474 |
| 息稅前利潤/營業總收入 (%) | 13.952 | 11.777 | 12.020 | 8.513 | 14.577 |
| 淨利潤/營業總收入 (%) | 8.647 | 8.052 | 8.719 | 6.718 | 14.105 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 150.506 | 157.529 | 154.935 | 161.741 | 107.449 |
| 價值變動淨收益/利潤總額(%) | -0.343 | -5.763 | -5.709 | -3.723 | 8.085 |
| 營業外收支淨額/利潤總額(%) | -0.062 | -7.607 | 0.645 | -0.106 | 0.995 | 償債能力分析 |
| 流動比率 (X) | 2.158 | 2.131 | 2.519 | 1.880 | 2.217 |
| 速動比率 (X) | 1.344 | 1.340 | 1.597 | 0.896 | 1.109 |
| 資產負債率 (%) | 49.951 | 49.387 | 47.243 | 39.739 | 35.183 |
| 帶息債務/全部投入資本 (%) | 38.208 | 36.622 | 33.212 | 24.232 | 15.367 |
| 股東權益/帶息債務 (%) | 145.729 | 155.175 | 177.147 | 282.011 | 492.789 |
| 股東權益/負債合計 (%) | 99.002 | 100.885 | 110.658 | 150.611 | 183.280 |
| 利息保障倍數 (X) | 3.694 | 5.375 | 7.906 | 5.025 | -342.766 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 82.191 | 73.087 | 77.061 | 75.320 | 63.743 |
| 存貨周轉天數 (天) | 378.999 | 303.811 | 351.690 | 359.057 | 344.748 |
| 備註： | 即時報價更新時間為 06/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
